KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.
Department of Cardiology, Saisei-kai Kurihashi Hospital, Saitama, Japan.
Y
Y
Endoh
R
R
Hanai
K
K
Uto
M
M
Uno
H
H
Nagashima
A
A
Narimatsu
T
T
Takizawa
S
S
Onishi
H
H
Kasanuki
D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D000941:Antigens; D000951:Antigens, Neoplasm; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D006023:Glycoproteins; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D018396:Mucin-1; D009077:Mucins; D010446:Peptide Fragments / Q000097:blood*; D011347:Procollagen / Q000097:blood*
D000889:Anti-Arrhythmia Agents; D000941:Antigens; D000951:Antigens, Neoplasm; D015415:Biomarkers; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D002097:C-Reactive Protein; D000638:Amiodarone